12th Sep 2013 12:57
LONDON (Alliance News) - Oxford BioMedica PLC said Thursday that Chief Financial Officer Timothy Watts had bought 400,000 shares at a price of 2.50 pence each.
The purchase took his total holding to nearly 3.7 million shares, still less than 1% of the company.
Shares in the company, which develops gene-based medicines, were trading up 14%, or 0.34 pence, at 2.79 pence Thursday morning.
By Philip Nye; [email protected]
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica